3.9 Article

TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients

Related references

Note: Only part of the references are listed.
Article Obstetrics & Gynecology

Prasterone in the treatment of mild to moderate urge incontinence: an observational study

Claudia Colla Ruvolo et al.

Summary: This study assessed the effects of prasterone compared with hyaluronic acid on urinary urgency symptoms in women with genitourinary syndrome of menopause. The results showed that prasterone had a better effect in improving urinary urgency symptoms and quality of life compared to hyaluronic acid. However, further studies with a larger population are needed to confirm these findings.

MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2022)

Article Obstetrics & Gynecology

Intravaginal 6.5 mg prasterone administration in postmenopausal women with overactive bladder syndrome: A pilot study

Maria Grazia Matarazzo et al.

Summary: This study suggests that vaginally administered prasterone can significantly improve symptoms of overactive bladder syndrome in postmenopausal women, as well as improve quality of life and VVA. Results showed significant improvements in urinary incontinence and VVA after 12 weeks of prasterone treatment.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)

Article Endocrinology & Metabolism

Overactive bladder syndrome treatment with ospemifene in menopausal patients with vulvovaginal atrophy: improvement of sexuality?

Michele Carlo Schiavi et al.

GYNECOLOGICAL ENDOCRINOLOGY (2018)

Article Medicine, General & Internal

Urinary incontinence in women

Yoshitaka Aoki et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Medicine, General & Internal

Mid-urethral sling operations for stress urinary incontinence in women

Abigail A. Ford et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Article Obstetrics & Gynecology

Validation of the Female Sexual Function Index (FSFI) for web-based administration

Catrina C. Crisp et al.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2015)

Review Medicine, General & Internal

Oestrogen therapy for urinary incontinence in postmenopausal women

June D. Cody et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)

Article Obstetrics & Gynecology

Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse

Sushma Srikrishna et al.

INTERNATIONAL UROGYNECOLOGY JOURNAL (2010)

Review Pharmacology & Pharmacy

Solifenacin succinate for the treatment of symptoms of overactive bladder

Maria Maniscalco et al.

CLINICAL THERAPEUTICS (2006)

Article Urology & Nephrology

Prevalence and burden of overactive bladder in the United States

WF Stewart et al.

WORLD JOURNAL OF UROLOGY (2002)